Recently, researchers found that TAK1 inhibition induces apoptosis in KRAS-dependent colon cancers and promotes NF-κB-dependent cell death in AML cells in vitro and in vivo45,46. The gene discussed is NFKB1; the disease is malignant colon neoplasm.